Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Kiarash Kojouri"'
Autor:
Mohamed L. Sorror, Ted A. Gooley, Barry E. Storer, Aaron T. Gerds, Mikkael A. Sekeres, Bruno C. Medeiros, Eunice S. Wang, Paul J. Shami, Kehinde Adekola, Selina Luger, Maria R. Baer, David A. Rizzieri, Tanya M. Wildes, Jamie Koprivnikar, Julie Smith, Mitchell Garrison, Kiarash Kojouri, Tammy A. Schuler, Wendy M. Leisenring, Lynn E. Onstad, Pamela S. Becker, Jeannine S. McCune, Stephanie J. Lee, Brenda M. Sandmaier, Frederick R. Appelbaum, Elihu H. Estey
Publikováno v:
Blood. 141:295-308
We designed a prospective, observational study enrolling patients presenting for treatment of acute myeloid leukemia (AML) at 13 institutions to analyze associations between hematopoietic cell transplantation (HCT) and survival, quality of life (QOL)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c18ac43f88e08919cf31ab19bf2deca
https://doi.org/10.1182/blood.2022016916
https://doi.org/10.1182/blood.2022016916
Autor:
Jordan Gauthier, Bianca Furtuna, Jacopo Mangiavacchi, Shahrzad Gholami, Juan Lavista Ferres, Rahul Dodhia, Amir T. Fathi, Andrew M. Brunner, Aaron T. Gerds, Mikkael A. Sekeres, Bruno C. Medeiros, Eunice S. Wang, Paul J Shami, Kehinde Adekola, Selina M. Luger, Maria R. Baer, David A Rizzieri, Tanya Wildes, Jamie L. Koprivnikar, Julie Smith, Mitchell A. Garrison, Kiarash Kojouri, Frederick R. Appelbaum, Mary-Elizabeth M. Percival, Stephanie J. Lee, Mohamed L. Sorror
Publikováno v:
Blood. 140:5254-5257
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e57b4eda21eed1734415cd02e3836ee
https://doi.org/10.1182/blood-2022-165437
https://doi.org/10.1182/blood-2022-165437
Autor:
Mohamed Lotfy, Sorror, Ted A, Gooley, Barry E, Storer, Aaron T, Gerds, Mikkael A, Sekeres, Bruno C, Medeiros, Eunice S, Wang, Paul J, Shami, Kehinde U A, Adekola, Selina M, Luger, Maria R, Baer, David A, Rizzieri, Tanya, Wildes, Jamie, Koprivnikar, Julie, Smith, Mitchell, Garrison, Kiarash, Kojouri, Tammy A, Schuler, Wendy M, Leisenring, Lynn, Onstad, Pamela S, Becker, Jeannine S, McCune, Stephanie J, Lee, Brenda M, Sandmaier, Frederick R, Appelbaum, Elihu, Estey
Publikováno v:
Blood.
We designed a prospective, observational study enrolling patients presenting for treatment of AML at 13 institutions to analyze associations between hematopoietic cell transplantation (HCT) and survival, quality of life (QOL), function and geriatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8eca021645cc579d68e5aa1a98d5831
https://pubmed.ncbi.nlm.nih.gov/36260765
https://pubmed.ncbi.nlm.nih.gov/36260765
Autor:
Mikkael A. Sekeres, Kiarash Kojouri, Amir T. Fathi, Tanya M. Wildes, Brenda M. Sandmaier, Bruno C. Medeiros, Mohamed L. Sorror, Jeannine S. McCune, Mitchell Garrison, Barry E. Storer, Stephanie J. Lee, Sudipto Mukherjee, Pankit Vachhani, Frederick R. Appelbaum, Eunice S. Wang, Jennifer E. Nyland, Maria R. Baer, Mahmoud Elsawy, Pamela S. Becker, Julie C. Smith, David A. Rizzieri, Wendy M. Leisenring, Lynn Onstad, Esteban Peña, Jamie Koprivnikar, Elihu H. Estey, Selina M. Luger, Paul J. Shami, Aaron T. Gerds, Andrew M. Brunner, Kehinde Adekola
Publikováno v:
Blood. 138(5)
Less-intensive induction therapies are increasingly used in older patients with acute myeloid leukemia (AML). Using an AML composite model (AML-CM) assigning higher scores to older age, increased comorbidity burdens, and adverse cytogenetic risks, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746d4fcfeb0b2cbea3659e3298a245e2
https://pubmed.ncbi.nlm.nih.gov/34351370
https://pubmed.ncbi.nlm.nih.gov/34351370
Autor:
Oliver W. Press, Kiarash Kojouri, Mary Philip, David Wu, Andrei R. Shustov, Edward N. Libby, Jennifer E. Roden, Stephen D. Smith, Tara L. Chen, Daniel Martin, Ajay K. Gopal, Alan Langerak, Lihua E. Budde, Ted Gooley, Eric Y. Chen
Publikováno v:
British Journal of Haematology. 183:601-607
We sought to develop a safe and effective outpatient salvage regimen by replacing ifosfamide within the (R)ICE (rituximab, ifosfomide, carboplatin, etoposide) regimen with bendamustine (T(R)EC) via a multicentre phase I/II study for patients with rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a3a7a6d8af8765f970390a18856be3
https://doi.org/10.1111/bjh.15585
https://doi.org/10.1111/bjh.15585
Autor:
Mitchell Garrison, Jeannine S. McCune, Barry E. Storer, Selina M. Luger, Frederick R. Appelbaum, Tanya M. Wildes, Brenda M. Sandmaier, Andrew M. Brunner, Kehinde Adekola, Pamela S. Becker, Mikkael A. Sekeres, Elihu H. Estey, David A. Rizzieri, Bruno C. Medeiros, Wendy Leisinring, Paul J. Shami, Jamie Koprivnikar, Mohamed L. Sorror, Maria R. Baer, Lynn Onstad, Eunice S. Wang, Kiarash Kojouri, Tammy Schuler, Stephanie J. Lee, Aaron T. Gerds, Amir T. Fathi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S185
Context Acute myeloid leukemia (AML) has a median survival of 6-12 months, with no major improvement over the last two decades. AML is a disease of elderly patients. Less-intensive induction therapies increasingly used in older patients, presuming th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::662a3379886409e9b86efb9e2af4200b
https://doi.org/10.1016/s2152-2650(20)30722-9
https://doi.org/10.1016/s2152-2650(20)30722-9
Autor:
Frederick R. Appelbaum, Julie C. Smith, Sophie L. Fleuret, Eunice S. Wang, Bruno C. Medeiros, Kehinde Adekola, Jennifer E. Nyland, Jamie Koprivnikar, Ylinne Lynch, Kiarash Kojouri, Tanya M. Wildes, Brenda M. Sandmaier, Selina M. Luger, Maria R. Baer, Pamela S. Becker, Mohamed L. Sorror, Elihu H. Estey, David A. Rizzieri, Aaron T. Gerds, Rachelle R. Moore, Mikkael A. Sekeres, Mary-Elizabeth M. Percival, John P. Galvin, Paul J. Shami, Barry E. Storer, Stefan Faderl, Mitchell Garrison, Sudipto Mukherjee
Publikováno v:
Blood. 132:207-207
Introduction: Survival rates continue to improve after allogeneic HCT (Gooley et al, NEJM, 2013). Population-based studies also indicate overall improvement in survival of older (60-80 years old) AML patients (pts) (Bower, Blood Cancer Journal, 2016)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff7a97ce5a6c12c714aafee94f91a5a5
https://doi.org/10.1182/blood-2018-99-113094
https://doi.org/10.1182/blood-2018-99-113094
Autor:
Bruno C. Medeiros, Paul J. Shami, Maria R. Baer, Elihu H. Estey, Mary-Elizabeth M. Percival, Ylinne Lynch, Stefan Faderl, Tanya M. Wildes, Brenda M. Sandmaier, Eunice S. Wang, Selina Luger, Frederick R. Appelbaum, John P. Galvin, Kehinde Adekola, Aaron T. Gerds, Barry E. Storer, Jamie Koprivnikar, Mitchell Garrison, Mohamed L. Sorror, Rachelle R. Moore, Sudipto Mukherjee, Jennifer E. Nyland, Pamela S. Becker, Julie C. Smith, Sophie L. Fleuret, David A. Rizzieri, Mikkael A. Sekeres, Kiarash Kojouri
Publikováno v:
Blood. 132:1388-1388
Introduction: Acute myeloid leukemia (AML) is most frequently diagnosed in older patients (pts), whose median survival is less than 1 year. Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment. However, older pts of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2f3f345df7d227684a2dac15b7711e
https://doi.org/10.1182/blood-2018-99-112672
https://doi.org/10.1182/blood-2018-99-112672
Autor:
Kiarash Kojouri, Vikki A. Canfield, S K. Kaneaster, Jesus E. Medina, Carl Bogardus, Greg A. Krempl, Samuel Brandon Hancock
Publikováno v:
The Laryngoscope. 118:1357-1361
Objectives/Hypothesis: To assess the efficacy of paclitaxel, ifosfamide, and cisplatinum induction chemotherapy plus concurrent chemoradiation in the treatment of stage III and IV base of tongue cancer. Study Design: Subgroup analysis of patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46424664965a57815b0114e878e87a9e
https://doi.org/10.1097/mlg.0b013e318175336a
https://doi.org/10.1097/mlg.0b013e318175336a
Autor:
Howard Ozer, Kiarash Kojouri, Farrukh T. Awan, Mehdi Hamadani, Jawad K. Khan, Arafat Tfayli, Lubna N Chaudhary
Publikováno v:
Journal of Oncology Pharmacy Practice. 13:69-75
Objective. The last decade has witnessed the great impact of 5-hydroxytryptamine-3 receptor (5-HT3) antagonists in revolutionizing the management of platinum-based chemotherapy–induced acute nausea and vomiting (CINV). However, despite the availabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42caf83cb2d347dac2b3f323b0bd2917
https://doi.org/10.1177/1078155207078137
https://doi.org/10.1177/1078155207078137